Fei Lee
Impact in
-
- NF-κB Signaling Pathways
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 7
- Plasma Applications and Diagnostics 1
- Oncology 7
- CAR-T cell therapy research 6
- Lung Cancer Research Studies 1
- Co-authors
- Francis M. Sirotnak (1 shared paper)Howard I. Scher (1 shared paper)Jing Chen (1 shared paper)Yuhong She (1 shared paper)Adriana Haimovitz‐Friedman (1 shared paper)Mark G. Kris (1 shared paper)F. M. Sirotnak (1 shared paper)Vincent A. Miller (1 shared paper)
- Journals
- Cancer Research (3 papers)Journal of Biological Chemistry (2 papers)Journal of Immunotherapy (1 paper)Journal of Nuclear Medicine (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Fei Lee
16 papers receiving 337 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 70
- Oncology 119
- Pulmonary and Respiratory Medicine 95
- Immunology 54
- Toxicology 6
Countries citing papers authored by Fei Lee
This map shows the geographic impact of Fei Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Lee more than expected).
Fields of papers citing papers by Fei Lee
This network shows the impact of papers produced by Fei Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Lee. The network helps show where Fei Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer. | 2002 | 84 |
| 2 | The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates radiation response of human tumors in nude mice, with a marked improvement in therapeutic index. | 2003 | 58 |
| 3 | 2013 | 57 | |
| 4 | 2012 | 43 | |
| 5 | 2008 | 25 | |
| 6 | 2021 | 24 | |
| 7 | 2000 | 23 | |
| 8 | 2021 | 19 | |
| 9 | 2000 | 4 | |
| 10 | 2019 | 2 | |
| 11 | 2017 | 1 | |
| 12 | 2019 | 1 | |
| 13 | 2010 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2019 | 1 |
About Fei Lee
Fei Lee is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Biotechnology, Immunology and Molecular Biology, having authored 16 papers that have together received 345 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), CAR-T cell therapy research (6 papers), Cancer Research and Treatments (3 papers), NF-κB Signaling Pathways (2 papers), Immunotherapy and Immune Responses (2 papers), Lung Cancer Research Studies (1 paper), Bioactive Compounds and Antitumor Agents (1 paper) and Plasma Applications and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (70 citations), Oncology (119 citations), Pulmonary and Respiratory Medicine (95 citations), Immunology (54 citations) and Toxicology (6 citations). Fei Lee has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Francis M. Sirotnak, Howard I. Scher, Jing Chen, Yuhong She, Adriana Haimovitz‐Friedman, Mark G. Kris, F. M. Sirotnak, Vincent A. Miller, Jing Chen and Athena Sudom. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Journal of Immunotherapy, Journal of Nuclear Medicine and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.